000 01151 a2200337 4500
005 20250512082833.0
264 0 _c19850618
008 198506s 0 0 eng d
022 _a0190-9622
024 7 _a10.1016/s0190-9622(85)70086-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCristofolini, M
245 0 0 _aThe role of etretinate (Tegison; Tigason) in the management of keratoacanthoma.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_cApr 1985
300 _a633-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aBiopsy
650 0 4 _aEtretinate
_xtherapeutic use
650 0 4 _aFacial Dermatoses
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aKeratoacanthoma
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSkin
_xpathology
700 1 _aPiscioli, F
700 1 _aZumiani, G
700 1 _aScappini, P
773 0 _tJournal of the American Academy of Dermatology
_gvol. 12
_gno. 4
_gp. 633-8
856 4 0 _uhttps://doi.org/10.1016/s0190-9622(85)70086-2
_zAvailable from publisher's website
999 _c3994710
_d3994710